Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

AGM Trading Update

27 Jan 2023 07:00

RNS Number : 0331O
Avon Protection PLC
27 January 2023
 

27 January 2023

Avon Protection plc

("Avon Protection" or "the Group")

AGM Trading Update

Avon Protection is pleased to announce a trading update for the first quarter of its 2023 financial year ("Q1" or the "Period"), ahead of its Annual General Meeting today.

 

Respiratory and head protection sales were at similar levels to Q1 2022, following a strong final quarter in respiratory last year. Overall, revenue in Q1 was up 6% versus last year, driven by the previously anticipated increase in sales of armour products.

 

Work to ramp up production on the Next-Generation IHPS helmet is ongoing, ahead of first deliveries in H2. The First Article Testing process for the ACH GEN II helmet is progressing well, with initial revenue expected in the first half of 2024. Body armour pressing and assembly is progressing as planned, though costs per unit remain high. We continue to expect armour production to end in Q3, with completion of deliveries by the end of the financial year.

The Group has a strong order pipeline for our leading respiratory products and further growth in demand is expected for head protection range. Due to the normal seasonality and timing of order receipts, revenue will be weighted to the second half, with FY23 expected to represent a year of good progress for Avon Protection.

 

Bruce Thompson, Non-Executive Chair, said:

"Jos Sclater joined Avon Protection as our new Chief Executive Officer at the start of this month and we welcome him to the Group. We look forward to making further progress on our key operational and strategic initiatives as we enter a new chapter of delivery, improvement and growth under his leadership."

 

Avon Protection will report its Interim Results for the six months ending 31 March 2023 on 23 May 2023.

 

For further enquiries, please contact:

 

Avon Protection plc

Jos Sclater, Chief Executive Officer

+44 1225 896 848

Rich Cashin, Chief Financial Officer

Rory Wiltshire, Investor Relations Manager

MHP

Tim Rowntree

+44 7710 032 657

Alan Tovey

avonprotection@mhpgroup.com

Pete Lambie

 

 

Legal Entity Identifier: 213800JM1AN62REBWA71

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR") EU no.596/2014. Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

About Avon Protection:

Avon Protection make products that are trusted to protect the world's militaries and first responders.

Our dedicated teams achieve this by developing mission-critical solutions that enhance our customers' performance, efficiency and capability, whilst providing ever-increasing levels of protection.

With a portfolio that includes respiratory and head protection systems, we are renowned for our innovative thinking and our steadfast approach to manufacturing unrivalled products.

For further information, please visit our website www.avon-protection-plc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMGZGZMGVKGFZZ
Date   Source Headline
15th May 20251:00 pmRNSHolding(s) in Company
7th May 202510:00 amRNSDirectors'/PDMR Shareholding
6th May 202512:00 pmRNS-RNotice of Results & Investor Presentation via IMC
11th Apr 20254:00 pmRNSHolding(s) in Company
8th Apr 202511:00 amRNSDirectors'/PDMR Shareholding
27th Mar 20252:00 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSQ2 trading update
20th Mar 202510:00 amRNSHolding(s) in Company
11th Mar 20255:00 pmRNSDirector/PDMR Shareholding
6th Mar 20253:00 pmRNSDirectors'/PDMR Shareholdings
4th Mar 20254:00 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSNext Generation IHPS Delivery Order
14th Feb 20252:00 pmRNSDirectors'/PDMR Shareholding
11th Feb 20254:00 pmRNSHolding(s) in Company
7th Feb 20254:00 pmRNSFinal Dividend Currency Exchange Rate
5th Feb 20254:00 pmRNSDirectors'/PDMR Shareholdings
31st Jan 202512:00 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement
27th Jan 20253:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNSThales UK Contract Renewal
7th Jan 20259:00 amRNSDirectors'/PDMR Shareholding
6th Jan 20257:00 amRNSNext Generation IHPS Delivery Order
12th Dec 20242:00 pmRNSHolding in Company
10th Dec 20249:00 amRNSNotice of Annual Report & Accounts and AGM 2025
6th Dec 202411:00 amRNSDirectors'/PDMR Shareholding
28th Nov 20245:00 pmRNSDirector/PDMR Shareholding
19th Nov 20242:00 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSPreliminary Results
6th Nov 20242:00 pmRNSHolding in Company
6th Nov 202410:00 amRNSDirectors'/PDMR Shareholding
25th Oct 202411:05 amRNSAppointment of Joint Corporate Broker
22nd Oct 20247:00 amRNSNotice of Results
8th Oct 202410:00 amRNSDirectors'/PDMR Shareholding
2nd Oct 20243:05 pmRNSHolding(s) in Company
26th Sep 20246:05 pmRNSHolding(s) in Company
10th Sep 20243:30 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSInterim Dividend Currency Exchange Rate
7th Aug 20249:00 amRNSDirectors'/PDMR Shareholdings
1st Aug 20248:19 amRNSChange of Company Name
1st Aug 20247:00 amRNSHolding(s) in Company
29th Jul 202412:00 pmRNSPDMR Shareholdings
25th Jul 20247:00 amRNSNew delivery order & updated FY 2024 guidance
10th Jul 20249:00 amRNSNotification of transaction of PDMR
8th Jul 202412:00 pmRNSDirectors'/PDMR Shareholdings
6th Jun 20243:00 pmRNSDirectors'/PDMR Shareholdings
30th May 20245:00 pmRNSHolding(s) in Company
28th May 20245:00 pmRNSHolding(s) in Company
24th May 20244:00 pmRNSHolding(s) in Company
21st May 20247:04 amRNSInterim Results
9th May 20247:00 amRNSUK MoD General Service Respirator order

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.